Point72 Asset Management, L.P. 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:12 pm Sale | 2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Point72 Asset Management, L.P. | 3,969 0.100% | -227,548 (-98.29%) | Filing |